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Abstract Nitroxides connected to indoles, tetrazoles, or 1,3,4-oxadi-
azoles were synthesized by conventional and microwave-assisted cy-
clization reactions. New approaches to pyrrole-, pyrazole-, and triazole-
annulated nitroxides are described. We showed that Diels–Alder reac-
tions of the N-tert-butoxycarbonyl derivative of (4,4,6,6-tetramethyl-
2,4,6,7-tetrahydro-5H-pyrrolo[3,4-c]pyridin-5-yl)oxidanyl gave polycy-
clic scaffolds condensed with a six-membered nitroxide.
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The importance of heterocyclic chemistry in the life sci-
ences was discovered at the nascent stage of organic chem-
istry, two centuries ago, with the isolation of alkaloids such
as quinine, morphine, and camptothecin. It later emerged
that endogenous neurotransmitters (histamine and sero-
tonin) contain heterocyclic units (imidazole and indole),
and today it is evident that heterocycles play an important
role in drug research and medicinal chemistry. Heterocycle-
containing drugs are used in all therapeutic areas, including
cardiovascular and metabolic diseases and diseases of the
central nervous system. Heterocycles are also present in an-
tiinflammatory, antiulcer, and antiinfective drugs, among
others.1
Nitroxides are stable free-radical species that have a
wide range of applications across many scientific disci-
plines, including materials science, biophysics, molecular
biology, and medicine.2 Nitroxides are often used as initia-
tors for the preparation of functional and complex poly-
mers, oxidants in organic chemistry,3 spin labels in identi-
fying structures of biomolecules,4 building blocks for or-
ganic magnets,5 and dynamic nuclear polarization agents in
NMR spectroscopy,6 among many other applications.
In recognition of the importance of these areas, we have
a long-standing interest in modifying heterocycles with sta-
ble nitroxide free radicals, principally through C–C bond
formation or by condensation procedures, bearing in mind
that heteroatoms should remain unaffected. In compliance
with this requirement, we have synthesized a number of ni-
troxides condensed with pyrrole, furan, pyridine,7 quino-
line,8 thiophene,9 isothiazole,10 or selenophene11 moieties,
thereby providing access to paramagnetic analogues of
omeprazole7 and tacrine12 and to their diamagnetic precur-
sors.
In continuation of this research interest, we examined
the synthesis of several new paramagnetic tetrazole, oxadi-
azole, indole, pyrazole, triazole, and pyrrole derivatives
modified with both five- and six-membered nitroxides in
the hope that they would serve as useful paramagnetic
building blocks for constructing spin labels, bioactive com-
pounds, or even supramolecular scaffolds.
Tetrazoles coupled to five- and six-membered nitroxide
were obtained by treatment of the paramagnetic nitriles
1a–c13–15 with two equivalents of sodium azide and ammo-
nium chloride in N,N-dimethylformamide16 at 130 °C in a
microwave oven to give the corresponding tetrazoles 2a–c
in 37–64% isolated yield (Scheme 1). As the nitroxide func-
tion was not destroyed, even on longer (two hours) micro-
wave irradiation, we decided to study this reaction with
more complex paramagnetic nitriles.
By applying this approach, we attempted a synthesis of
a 3,4-bis(tetrazolyl)pyrroline nitroxide. First, we synthe-
sized dinitrile 4 by treatment of bromo nitrile 39 with tetra-
ethylammonium cyanide in acetonitrile (Scheme 2). How-
ever, the reaction of dinitrile 4 with six equivalents of sodi-
um azide and ammonium chloride for a prolonged reaction
time (three hours) gave the monotetrazolyl derivative 5 in-
stead of the desired bistetrazolyl derivative. Treatment of© Georg Thieme Verlag  Stuttgart · New York — Synthesis 2014, 46, A–G
BB. Bognár et al. PaperSyn thesisbromo nitrile 3 under these reaction conditions, somewhat
unexpectedly, gave the tetrahydropyrrolo[3,4-b]pyrrole de-
rivative 7, offering a new approach for the synthesis of con-
densed pyrazole rings, albeit in low yield (27%). To obtain
some information on the mechanism of the reaction, we
examined the reaction of bromo nitrile 3 with sodium azide
in N,N-dimethylformamide at 50 °C. After heating the mix-
ture for 15 minutes, we were able to isolate an unstable yel-
low compound 6 that showed a nitrile band (2217 cm–1)
and an azide band (2108 cm–1) in its IR spectrum (see Sup-
porting Information), suggesting the formation of a β-azido
α,β-unsaturated nitrile intermediate that undergoes ring
closure to form the pyrazole derivative 7.
Scheme 2  Reagents and conditions: (a) Et4NCN (1.2 equiv), MeCN, re-
flux, 2 h, 74%; (b) NaN3 (6.0 equiv), NH4Cl (6.0 equiv), DMF, 3 h, 130 °C 
(MW), 43%; (c) NaN3 (2.0 equiv), DMF, 50 °C, 15 min., 35%; (d) NaN3 
(2.0 equiv), NH4Cl (2.0 equiv), DMF, 2 h, 130 °C (MW), 27%; (e) DMF, 2 
h, 130 °C (MW), 30%.
The spin-labeled tetrazole 2a proved to be a useful sub-
strate for transformation into a substituted 1,3,4-oxadiazole
by means of the Huisgen tetrazole rearrangement.17,18 By
heating tetrazole 2a in acetic anhydride at 90 °C in a micro-
wave oven, we obtained oxadiazole 8 in 63% yield, whereas
conventional heating of tetrazole 2a in acetic anhydride
gave oxadiazole 8 in 45% yield. Acylation of tetrazole 2a
with acyl chloride 913 in refluxing toluene containing pyri-
dine gave the biradical compound 10, providing a new ap-
proach for the synthesis of biradicals19 (Scheme 3).
Scheme 3  Reagents and conditions: (a) Method A: Ac2O (excess), 1 h, 
90 °C (MW), 63%; Method B: Ac2O (excess), 1 h, 90 °C, 45%; (b) 9 (1.0 
equiv), py (1.0 equiv), toluene, 90 °C, 1 h, 54%.
We have previously reported7 a synthesis of 1,1,3,3-te-
tramethyl-1,2,3,5-tetrahydropyrrolo[3,4-c]pyrrole scaffold
lacking any substituent on the pyrrole ring. A possible route
to 2-(ethoxycarbonyl)pyrroles and -indoles is provided by
the Hemetsberger–Knittel reaction;20,21 this inspired us to
attempt syntheses of pyrrole-annulated five- or six-mem-
bered nitroxides.
Condensation of the α,β-unsaturated nitroxide alde-
hydes 11a and 11b22,23 with ethyl 2-azidoacetate in anhy-
drous ethanol at –10 °C in the presence of sodium ethoxide
as a base gave the corresponding vinyl azides 12a and 12b
in moderate yields (19–35%).24 The vinyl azides were isolat-
ed and heated in anhydrous hexane with microwave irradi-
ation to give the cyclized products 13a and 13b in 70–82%
yield. To extend this work to substituted indoles, the para-
magnetically modified benzaldehyde 1425 was treated with
ethyl 2-azidoacetate under the above conditions to give ni-
troxide 15a in satisfactory (60%) yield. However, an attempt
to cyclize nitroxide 15a to form the spin-labeled indole-2-
carboxylate 16a failed. We assume that the indole ring-for-
mation reaction involves a free-radical step or a nonionic
reactive intermediate-producing step. This idea was sup-
ported by the fact that the corresponding diamagnetic de-
rivative 15b, obtained by acetylation of the N-hydroxy de-
rivative of 15a,26 underwent cyclization smoothly on micro-
wave heating to give the acetate 16b. Subsequent removal
of the acetyl group by Zemplen’s method27 gave our target
compound 16a (Scheme 4).
Scheme 1  Reagents and conditions: (a) NaN3 (2.0 equiv), NH4Cl (2.0 
equiv), DMF, 2 h, 130 °C (MW), 51–58%.
R CN R
1
2
N
H
N
N
N
a
1, 2 a b c
N
O
N
O
N
O
R
•••
N
CN
O
Br
a
N
CN
O
NC
N
CN
O
N3
N
3 4
N
O
NC NH
N
N
N
5
b
c
N
HN
O
6 7
d
e
• •
•••
N
O
O
N
N
2a
N
O
N
N
N
O
O
8
10
+
N
COCl
O
9
a
b
•
••
•© Georg Thieme Verlag  Stuttgart · New York — Synthesis 2014, 46, A–G
CB. Bognár et al. PaperSyn thesisScheme 4  Reagents and conditions: (a) NaOEt (2.0 equiv), N3CH2CO2Et 
(2.0 equiv), anhyd EtOH, –10 °C, 3 h, 19–60%; (b) 12a, 12b, or 15b, an-
hyd hexane, 150 °C (MW), 15 min, 65–82%; (c) 15a (1.0 equiv), sodium 
ascorbate (5.0 equiv), aq 1,4-dioxane (40 °C), N2, then Et3N (1.1 equiv), 
AcCl (1.1 equiv), 0 °C to r.t., 73%; (d) NaOEt (3.0 equiv), EtOH, 30 min. 
r.t., 71%.
We also examined the original Hemetsberger–Knittel
reaction, and we found that ring closure occurred in the
presence of 0.1 equivalents of 2,2,6,6-tetramethylpiperi-
dine-1-yloxyl (TEMPO ); however, many byproducts (decar-
boxylated products, dihydroindoles, dimers, etc.; see Sup-
porting Information) were formed under the thermolysis
conditions (Scheme 5).
Scheme 5  Products of the Hemetsberger–Knittel reaction in the pres-
ence of TEMPO, based on a GC/MS study.
To synthesize the pyrrolo[3,4-c]pyridine isomer of the
13b scaffold, we used the Barton–Zard reaction.28 Elimina-
tion of hydrogen bromide from the bromo nitro derivative
1729 by treatment with 1,8-diazabicyclo[5.4.0]undec-7-ene
(DBU) in acetonitrile gave nitro compound 18. On heating
with sodium azide in dimethyl sulfoxide, nitro compound
18 gave the condensed triazole derivative 19,30 whereas
treatment of 18 with methyl isocyanoacetate in tetrahydro-
furan in the presence of DBU gave the condensed pyrrole
derivative 20a.31 We surmised that not only is compound
20a a paramagnetic heterocyclic unit, but also that it can
also be regarded as a precursor of a diene. Diene-like activi-
ty of the pyrrole ring was demonstrated by preparing the
corresponding N-tert-butoxycarbonyl derivative 20b, by
treating 20a with di-tert-butyl dicarbonate in the presence
of potassium tert-butoxide in tetrahydrofuran.32 Heating a
mixture of compound 20b with diethyl acetylenedicarbox-
ylate in refluxing toluene gave adduct 21, providing a new
possibility for the synthesis of polycyclic ring systems33
containing a nitroxide unit (Scheme 6).
Scheme 6  Reagents and conditions: (a) DBU (1.1 equiv), MeCN, reflux, 
15 min, 48%; (b) NaN3 (2.0 equiv), DMSO, 90 °C, 2 h, 47%; (c) NCCH2-
CO2Me (1.1 equiv), DBU (1.2 equiv), THF, 0 °C to r.t., 12 h, 53%; 
(d)(Boc)2O (1.1 equiv), t-BuOK (0.4 equiv), THF, reflux, 19 h, 73%; (e) 
EtO2CC≡CCO2Et (2.0 equiv), toluene, reflux, 48 h, 34%.
In conclusion, we have developed a synthesis of pyrro-
line or tetrahydropyridine nitroxide-condensed pyrrole,
pyrazole, or triazole heterocycles. By means of conventional
or microwave-assisted heating, we synthesized nitroxides
linked to tetrazole, indole, or oxadiazole moieties. We con-
cluded that the classical Hemetsberger–Knittel indole syn-
thesis is perturbed by the presence of stable nitroxide free
radicals, whereas nitroxide–indole conjugates can be pre-
pared directly through reversible protection of the nitrox-
ide moiety. Further studies on pyrrole-condensed nitrox-
ides are in progress in our laboratory.
Melting points were determined with a Boetius micro-melting point
apparatus and are uncorrected. Elemental analyses (C, H, N, and S)
were performed with a Fisons EA 1110 CHNS elemental analyzer.
Mass spectra were recorded on a ThermoQuest Automass Multi spec-
trometer. NMR spectra were recorded on a Bruker Avance III Ascend
500 spectrometer; chemical shifts are referenced to TMS. The para-
magnetic compound was reduced with five equivalents of hydrazo-
benzene/radical. Measurements were performed at a probe tempera-
ture of 298 K in CDCl3 solution. ESR spectra were recorded on Minis-
cope MS 200 in 10–4 M CHCl3 solution. All monoradicals gave a triplet
line at aN = 14.4 G; biradical 10 (aN1 = 7.2 G; aN2 = 14.4 G) gave a quin-
tet line. Microwave-assisted reactions were carried out in a Milestone
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DB. Bognár et al. PaperSyn thesisMicroSYNTH Labstation in sealed tubes (15 bar) with temperature
control (fiber optic probe). The total irradiation time was as indicated.
IR spectra were recorded a with Bruker Alpha FT-IR instrument with
ATR support (ZnSe plate). Flash column chromatography was per-
formed on Merck Kieselgel 60 (0.040–0.063 mm). Qualitative TLC was
carried out on commercially available plates (20 × 20 × 0.02 cm) coat-
ed with Merck Kieselgel GF254. Compounds 1a,13 1b,14 1c,15 3,9 9,13
11a,22 11b,23 14,25 and 1729 were prepared according to published
procedures; other reagents were purchased from Aldrich or Alfa Ae-
sar.
Paramagnetic Tetrazoles 2a–c; General Procedure
A mixture of NaN3 (130 mg, 2.0 mmol), NH4Cl (107 mg, 2.0 mmol),
and the appropriate paramagnetic nitrile 1a–c (1.0 mmol) in DMF (10
mL) was heated in a sealed tube by microwave irradiation for 2 h
(hold time) at 130 °C. The mixture was then cooled and concentrated
in vacuo. The residue was partitioned between 5% aq H2SO4 (10 mL)
and CHCl3 (15 mL). The organic phase was separated and the aqueous
phase was washed with CHCl3 (20 mL). The organic phases were then
combined, dried (MgSO4), filtered, concentrated, and purified by flash
column chromatography [silica gel, CHCl3–MeOH (4:1)].
[2,2,5,5-Tetramethyl-3-(1H-tetrazol-5-yl)-2,5-dihydro-1H-pyrrol-
1-yl]oxidanyl (2a)
Yellow crystals; yield: 120 mg (58%); mp 211–212 °C; Rf = 0.27
(CHCl3–MeOH, 4:1).
IR (ATR): 2981, 2863, 2732, 1684 cm–1.
1H NMR [?? MHz, CDCl3+ (PhNH)2–CDCl3]: δ = 6.51 (s, 1 H), 1.68 (s, 6
H), 1.48 (s, 6 H).
MS (EI): m/z (%) = 208 (69) [M+], 178 (26), 165 (69), 135 (100).
Anal. Calcd for C9H14N5O: C, 51.91; H, 6.78; N, 33.63. Found: C, 52.01;
H, 6.82; N, 33.58.
[2,2,6,6-Tetramethyl-4-(1H-tetrazol-5-yl)-1,2,5,6-tetrahydropyri-
din-1(2H)-yl]oxidanyl (2b)
?? ; yield: 113 mg (51%); mp 169–170 °C; Rf = 0.38 (CHCl3–MeOH,
9:1).
IR (ATR): 2982, 2928, 2856, 2756, 1647 cm–1.
MS (EI): m/z (%) = 222 (20) [M+], 192 (48), 149 (100).
Anal. Calcd for C10H16N5O: C, 54.04; H, 7.26; N, 31.51. Found: C, 53.90;
H, 7.13; N, 31.33.
[2,2,6,6-Tetramethyl-4-(1H-tetrazol-5-yl)piperidin-1-yl]oxidanyl 
(2c)
??; yield: 121 mg (54%); mp 169–170 °C; Rf = 0.23 (CHCl3–MeOH,
9:1).
IR (ATR): 2983, 2941, 2873, 1648 cm–1.
MS (EI): m/z (%) = 224 (10) [M+], 194 (3), 138 (100).
Anal. Calcd for C10H18N5O: C, 53.55; H, 8.09; N, 31.23. Found: C, 53.36;
H, 8.09; N, 31.19.
(3,4-Dicyano-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-1-yl)oxi-
danyl (4)
In a well-ventilated hood, Et4NCN (374 mg, 2.4 mmol; CAUTION: Poi-
sonous!) was added to a stirred solution of compound 3 (488 mg, 2.0
mmol) in dry MeCN (15 mL) at r.t.. The mixture was refluxed for 2 h
then cooled and concentrated. The residue was partitioned between
freshly prepared sat. aq FeSO4 (10 mL) and EtOAc (20 mL). The organic
phase was separated and the aqueous phase was extracted with
EtOAc (20 mL). (Note: The aqueous phase was stored in a hazardous-
materials container.) The organic extracts were combined, dried
(MgSO4), filtered, and concentrated. The residue was subjected to
flash column chromatography [silica gel, hexane–Et2O (2:1)] to give
orange crystals; yield: 288 mg (74%); mp 141–142 °C; Rf = 0.41
(hexane–Et2O, 2:1).
IR (ATR): 2982, 2915, 2852, 2234, 1648 cm–1.
MS (EI): m/z (%) = 190 (20) [M+], 160 (27), 145 (100).
Anal. Calcd for C10H12N3O: C, 63.14; H, 6.36; N, 22.09. Found: C, 63.25;
H, 6.29; N, 21.98.
[3-Cyano-2,2,5,5-tetramethyl-4-(1H-tetrazol-5-yl)-2,5-dihydro-
1H-pyrrol-1-yl]oxidanyl (5)
A mixture of NaN3 (390 mg, 6.0 mmol), NH4Cl (321 mg, 6.0 mmol),
and dinitrile 4 (190 mg, 1.0 mmol) in DMF (10 mL) in a sealed tube
was heated by microwave irradiation for 3 h (hold time) at 130 °C.
The mixture was then cooled and concentrated in vacuo. The residue
was partitioned between 5% aq H2SO4 (10 mL) and CHCl3 (15 mL). The
organic phase was separated and the aqueous phase was washed with
CHCl3 (20 mL). The organic phases were combined, dried (MgSO4), fil-
tered, concentrated, and purified by flash column chromatography
[silica gel, CHCl3–Et2O (4:1)] to give a yellow solid; yield: 91 (43%); mp
206–207 °C; Rf = 0.19 (CHCl3–MeOH, 9:1).
IR (ATR): 3167, 2922, 2852, 2236, 1658 cm–1.
MS (EI): m/z (%) = 233 (57) [M+], 218 (8), 213 (5) 42 (100).
Anal. Calcd for C10H13N6O: C, 51.49; H, 5.62; N, 36.03. Found: C, 51.28;
H, 5.65; N, 36.10.
(3-Azido-4-cyano-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-1-
yl)oxidanyl (6)
NaN3 (260 mg, 4.0 mmol) was added to a stirred bromo nitrile 3 (488
mg, 2.0 mmol) in DMF (5 mL) at r.t., and the mixture was stirred at
50 °C for 15 min. The mixture was then diluted with H2O (40 mL) and
extracted with Et2O (2 × 10 mL). The organic phase was dried
(MgSO4), filtered, and concentrated. The residue was purified by flash
column chromatography [silica gel, hexane–Et2O (4:1)] to give a yel-
low solid; yield: 144 (35%); mp 45–46 °C; Rf = 0.54 (hexane–Et2O, 2:1).
IR (ATR): 2978, 2928, 2217, 2108, 1619 cm–1.
MS (EI): m/z (%) = 206 (19) [M+], 147 (13), 107 (23), 43 (100).
Anal. Calcd for C9H12N5O: C, 52.42; H, 5.87; N, 33.96. Found: C, 52.31;
H, 5.79; N, 34.01.
(4,4,6,6-Tetramethyl-4,6-dihydropyrrolo[3,4-c]pyrazol-5(1H)-
yl)oxidanyl (7)
Method A: A mixture of NaN3 (130 mg, 2.0 mmol), NH4Cl (107 mg, 2.0
mmol), and bromo nitrile 3 (244 mg, 1.0 mmol) in DMF (10 mL) in a
sealed tube was heated by microwave irradiation for 2 h (hold time)
at 130 °C. The mixture was then cooled and concentrated under re-
duced pressure, and the residue was partitioned between brine (10
mL) and CHCl3 (15 mL). The organic phase was separated, and the
aqueous phase was washed with CHCl3 (20 mL). The organic phases
were combined, dried (MgSO4), filtered, concentrated, and purified by
flash column chromatography [silica gel, hexane–EtOAc (2:1)] to give
a yellow solid; 49 mg (27%); mp 217–218 °C; Rf = 0.22 (hexane–EtOAc,
2:1).
IR (ATR): 3353, 3231, 2974, 2927, 2853, 1670, 1617 cm–1.
MS (EI): m/z (%) = 180 (18) [M+], 165 (67), 150 (100), 135 (45).© Georg Thieme Verlag  Stuttgart · New York — Synthesis 2014, 46, A–G
EB. Bognár et al. PaperSyn thesisAnal. Calcd for C9H14N3O: C, 59.98; H, 7.83; N, 23.32. Found: C, 59.84;
H, 7.78; N, 23.28.
Method B: A solution of cyano azide 6 (103 mg, 0.5 mmol) in DMF (5
mL) was heated in a microwave oven for 2 h (hold time) at 130 °C. Af-
ter cooling, the solvent was concentrated off, the residue was parti-
tioned between brine (5 mL) and CHCl3 (10 mL). Workup as above
gave a yellow solid [yield: 27 mg (30%)] that was identical to that ob-
tained by Method A (mp, TLC, MS, and IR spectrum).
[2,2,5,5-Tetramethyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-2,5-dihy-
dro-1H-pyrrol-1-yl]oxidanyl (8)
Method A: Compound 2a (416 mg, 2.0 mmol) was dissolved in Ac2O (5
mL), and the mixture was heated in a microwave oven at 90 °C for 1 h
(hold time). The mixture was cooled then poured onto ice–water (50
mL) to give a precipitate. The precipitate was collected by filtration,
air-dried, and purified by flash column chromatography [silica gel,
hexane–EtOAc (2:1)] to give a yellow solid; yield: 280 mg (63%); mp
104–105 °C; Rf = 0.2 (hexane–EtOAc, 2:1).
IR (ATR): 2975, 2928, 2854, 1668, 1648, 1577 cm–1.
1H NMR [?? MHz, CDCl3 + (PhNH)2]: δ = 6.42 (s, 1 H), 2.57 (s, 3 H), 1.61
(s, 6 H), 1.28 (s, 6 H).
MS (EI): m/z (%) = 222 (53) [M+], 207 (45), 192 (26), 177 (100).
Anal. Calcd for C11H16N3O2: C, 59.44; H, 7.26; N, 18.91. Found: C,
59.33; H, 7.28; N, 18.73.
Method B: Compound 2a (416 mg, 2.0 mmol) was dissolved in Ac2O (5
mL), and the solution was heated 90 °C for 1 h in an oil bath. The mix-
ture was cooled, poured onto ice–water (50 mL), basified by adding
solid K2CO3 (pH 9), and extracted with CHCl3 (2 × 20 mL). The extracts
were dried (MgSO4), filtered, concentrated, and purified by flash col-
umn chromatography [silica gel, hexane–EtOAc (2:1)] to give a yellow
solid [yield: 200 mg (45%)] that was identical to the compound ob-
tained by Method A (mp, TLC, MS, and IR spectrum).
3,3′-(1,3,4-Oxadiazole-2,5-diyl)bis(2,2,5,5-tetramethyl-2,5-dihy-
dro-1H-pyrrol-1-yloxidanyl) (10)
A solution of acid chloride 9 (405 mg, 2.0 mmol) in anhyd toluene (5
mL) was added to a mixture of tetrazole 2a (416 mg, 2.0 mmol) and
pyridine (158 mg, 2.0 mmol) in anhyd toluene (10 mL). The mixture
was heated to 90 °C for 1 h then cooled. The solvent was evaporated
and the residue was dissolved in CHCl3 (20 mL). The solution was
washed successively with 5% aq H2SO4 (10 mL) and brine (20 mL). The
organic phase was dried (MgSO4), filtered, and concentrated. The res-
idue was purified by column chromatography [silica gel, hexane–EtO-
Ac (2:1)] to give a yellow solid; yield: 186 mg (54%); mp 185–186 °C;
Rf = 0.26 (hexane–EtOAc, 2:1).
1H NMR [?? MHz, CDCl3 + (PhNH)2]: δ = 6.56 (s, 2 H), 1.66 (s, 12 H),
1.43 (s, 12 H).
IR (ATR): 2977, 2930, 1706, 1644 cm–1.
MS (EI): m/z (%) = 346 (23) [M+], 286 (43), 271 (54), 67 (100).
Anal. Calcd for C18H26N4O3: C, 62.41; H, 7.56; N, 16.17. Found: C,
62.33; H, 7.30; N, 16.22.
Paramagnetic α-Azido Acrylates 12a, 12b, and 15a; General Proce-
dure
A solution of NaOEt, freshly prepared by dissolving Na (230 mg, 10.0
mmol) in EtOH (10 mL), was added dropwise over 10 min to a stirred
solution of the appropriate aldehyde (5.0 mmol) and EtO2CCH2N3
(1.29 g 10.0 mmol) in anhyd EtOH (15 mL) at –10 °C, and the mixture
was stirred at 0 °C for 2 h. The reaction was then quenched with sat.
aq NH4Cl (30 mL). CH2Cl2 (30 mL) was added, the phases were sepa-
rated, and the aqueous phase was washed with CH2Cl2 (2 × 20 mL).
The organic phases were combined, washed with brine (15 mL), dried
(MgSO4), filtered, concentrated, and purified by column chromatogra-
phy. Compounds 12a and 12b were stable for several days if stored in
a freezer (–20 °C). During workup, we observed spontaneous forma-
tion of the cyclized products 13a and 13b.
[3-(2-Azido-3-ethoxy-3-oxoprop-1-en-1-yl)-2,2,5,5-tetramethyl-
2,5-dihydro-1H-pyrrol-1-yl]oxidanyl (12a)
Yellow solid; yield: 488 (35%); mp ?? °C (dec); Rf = 0.55 (hexane–
EtOAc, 2:1).
IR (ATR): 2975, 2931, 2108, 1714, 1613 cm–1.
MS (EI): m/z (%) = 279 (6) [M+], 221 (20), 163 (31), 42 (100).
Anal. Calcd for C13H19N4O3: C, 55.90; H, 6.86; N, 20.06. Found: C,
55.74; H, 6.77; N, 19.99.
[4-(2-Azido-3-ethoxy-3-oxoprop-1-en-1-yl)-2,2,6,6-tetramethyl-
3,6-dihydropyridin-1(2H)-yl]oxidanyl (12b)
Orange solid; yield: 278 mg (19%); mp ?? °C (dec); Rf = 0.61 (hexane–
EtOAc, 2:1).
IR (ATR): 2977, 2933, 2106, 1710, 1606 cm–1.
1H NMR (?? MHz, CDCl3): δ (O-acetate) = 6.44 (s, 1 H), 5.90 (s, 1 H),
4.34–4.30 (q, J = 7.1 Hz, 2 H), 2.14 (s, 1 H), 1.38 (t, J = 7.1 Hz, 3 H), 1.37
(s, 3 H), 1.22 (d, J = 3.3 Hz, 6 H), 1.18 (s, 3 H).
MS (EI): m/z (%) = 293 (35) [M+], 220 (52), 162 (93), 42 (100).
Anal. Calcd for C14H21N4O3: C, 57.32; H, 7.22; N, 19.10. Found: C,
57.12; H, 7.07; N, 19.02.
{3-[4-(2-Azido-3-ethoxy-3-oxoprop-1-en-1-yl)phenyl]-2,2,5,5-te-
tramethyl-2,5-dihydro-1H-pyrrol-1-yl}oxidanyl (15a)
Brownish-yellow solid; yield: 1.06 g (60%); mp 75–76 °C; Rf = 0.51
(hexane–EtOAc, 2:1).
IR (ATR): 2972, 2114, 1700, 1603 cm–1.
MS (EI): m/z (%) = 355 (3) [M+], 239 (10), 224 (58), 42 (100).
Anal. Calcd for C19H23N4O3: C, 64.21; H, 6.52; N, 15.76. Found: C,
64.07; H, 6.35; N, 15.61.
Ethyl 3-{4-[1-(acetyloxy)-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyr-
rol-3-yl]phenyl}-2-azidoacrylate (15b)
Ascorbic acid (1.75 g, 10.0 mmol) was added in portions over 15 min
to a stirred solution of compound 15a (710 mg, 2.0 mmol) in 1,4-di-
oxane (20 mL) and H2O (10 mL) at 40 °C under N2. The solution was
then extracted with CHCl3 (2 × 20 mL), and the extracts were dried
(MgSO4). Et3N (220 mg, 2.2 mmol) and AcCl (172 mg, 2.2 mmol) were
added successively under N2 at 0 °C, and the solution was stirred at r.t.
for 1 h. EtOH (1 mL) was then added, the mixture was filtered, and the
filtrate was concentrated. The residue was treated with brine (10 mL)
and EtOAc (20 mL), and the phases were separated. The aqueous
phase was extracted with EtOAc (2 × 10 mL). The organic phases were
combined, dried (MgSO4), filtered, concentrated, and purified by
chromatography [silica gel, hexane–EtOAc (2:1)] to give a colorless
oil; yield: 581 (73%); Rf = 0.50 (hexane–EtOAc, 2:1).
IR (ATR): 2975, 2934, 2112, 1757, 1699, 1603, 1564 cm–1.© Georg Thieme Verlag  Stuttgart · New York — Synthesis 2014, 46, A–G
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Hz, 2 H), 6.91 (s, 1 H), 5.80 (s, 1 H), 4.42–4.38 (q, J = 7.1 Hz, 2 H), 2.21
(s, 3 H), 1.44–1.41 (t, J = 7.1 Hz, 3 H), 1.35 (s, 9 H), 1.29 (s, 3 H).
MS (EI): m/z (%) = 398 (2) [M+], 370 (12), 355 (8), 43 (100).
Anal. Calcd for C21H26N4O4: C, 63.30; H, 6.58; N, 14.06. Found: C,
63.14; H, 6.50; N, 13.99.
Cyclization of α-azido acrylates 2a, 12b, and 15b; General Proce-
dure
A solution of compound 12a, 12b, or 15b (1.0 mmol) in anhyd hexane
(5 mL) was heated in a sealed tube equipped with a Weflon disk at 70
W constant power for 10 min (total irradiation time). The solution
was then cooled to r.t., and the crude product was collected by filtra-
tion and washed with hexane.
[2-(Ethoxycarbonyl)-4,4,6,6-tetramethyl-4,6-dihydropyrrolo[3,4-
b]pyrrol-5(1H)-yl]oxidanyl (13a)
Yellow crystals; yield: 205 mg (82%); mp 173–174 °C; Rf = 0.61 (hex-
ane–EtOAc, 2:1).
IR (ATR): 3267, 2975, 2922, 1673, 1482, 1431 cm–1.
1H NMR [?? MHz, CDCl3 + (PhNH)2]: δ = 6.78 (s, 1 H), 4.41–4.37 (q, J =
6.8 Hz, 2 H), 1.48 (s, 6 H), 1.44–1.41 (t, J = 6.9 Hz, 3 H), 1.16 (s, 6 H).
MS (EI): m/z (%) = 251 (3) [M+], 221 (100), 206 (86), 160 (62).
Anal. Calcd for C13H19N2O3: C, 62.13; H, 7.62; N, 11.15. Found: C,
62.22; H, 7.58; N, 11.05.
[2-(Ethoxycarbonyl)-5,5,7,7-tetramethyl-1,4,5,7-tetrahydro-6H-
pyrrolo[2,3-c]pyridin-6-yl]oxidanyl (13b)
Orange crystals; yield: 185 mg (70%); mp 186–187 °C; Rf = 0.71 (hex-
ane–EtOAc, 2:1).
IR (ATR): 3326, 2989, 12977, 1677, 1510 cm–1.
MS (EI): m/z (%) = 265 (24) [M+], 235 (35), 220 (54), 192 (100).
Anal. Calcd for C14H21N2O3: C, 63.37; H, 7.98; N, 10.56. Found: C,
63.50; H, 7.99; N, 10.43.
Ethyl 6-[1-(acetyloxy)-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-
3-yl]-1H-indole-2-carboxylate (16b)
White crystals; yield: 240 mg (65%); mp 114–116 °C; Rf = 0.60 (hex-
ane–EtOAc, 2:1).
1H NMR (?? MHz, CDCl3): δ = 7.65 (d, J = 8.3 Hz, 1 H), 7.40 (s, 1 H), 7.23
(s, 1 H), 7.17 (d, J = 8.2 Hz, 1 H), 5.76 (s, 1 H), 4.46–4.41 (q, J = 7.1 Hz, 2
H), 2.22 (s, 3 H), 1.58 (s, 6 H), 1.46–1.43 (t, J =7.2 Hz, 3 H), 1.37 (s, 6 H).
13C NMR (?? MHz, ??): δ = 171.6, 161.7, 145.1, 136.6, 132.9, 131.4,
128.1, 126.9, 122.3, 121.2, 110.5, 108.5, 72.2, 68.2, 61.1, 27.9, 23.5,
19.3, 14.4.
MS (EI): m/z (%) = 370 (15) [M+], 355 (92), 313 (98), 43 (100).
Anal. Calcd for C21H26N2O4: C, 68.09; H, 7.07; N, 7.56. Found: C, 67.94;
H, 7.05; N, 7.69.
{3-[2-(Ethoxycarbonyl)-1H-indol-6-yl]-2,2,5,5-tetramethyl-2,5-di-
hydro-1H-pyrrol-1-yl}oxidanyl (16a)
Freshly prepared NaOEt [Na metal (69 mg, 3.0 mmol) dissolved in an-
hyd EtOH (5 mL)] was added to a solution of acetate 16b (370 mg, 1.0
mmol) in dry EtOH (10 mL). The mixture was stirred at r.t. for 1 h then
concentrated. The residue was partitioned between ?? aq NH4Cl (10
mL) and CH2Cl2 (20 mL), and the organic phase was separated and
dried (MgSO4). MnO2 (87 mg, 1.0 mmol) was added and O2 was bub-
bled through the mixture for 30 min. The mixture was then filtered
and concentrated. The residue was purified by column chromatogra-
phy [silica gel, hexane–EtOAc (2:1)] to give a yellow solid; yield: 232
mg (71%); mp 136–137 °C; Rf = 0.55 (hexane–EtOAc, 2:1).
IR (ATR): 3320, 2974, 2922, 2852, 1677, 1521 cm–1.
MS (EI): m/z (%) = 327 (58) [M+], 312 (20), 297 (100), 282 (47), 97 (80).
Anal. Calcd for C19H23N2O3: C, 69.70; H, 7.08; N, 8.56. Found: C, 69.51;
H, 7.06; N, 8.33.
(2,2,6,6-Tetramethyl-4-nitro-3,6-dihydropyridin-1(2H)-yl)oxi-
danyl (18)
DBU (480 mg, 3.1 mmol) was added to a solution of compound 17
(840 mg, 3.0 mmol) in anhyd MeCN (10 mL), and the mixture was re-
fluxed for 15 min. The mixture was then cooled to r.t. and concentrat-
ed. The residue was partitioned between EtOAc (20 mL) and 5% aq H2-
SO4 (10 mL). The organic phase was separated, dried (MgSO4), filtered,
and concentrated. The residue was purified by flash chromatography
[silica gel, hexane–EtOAc (2:1)] to give deep-orange crystals; yield:
288 mg (48%); mp 50–51 °C; Rf = 0.41 (hexane–Et2O, 2:1).
IR (ATR): 2974, 2924, 2853, 1680, 1516 cm–1.
1H NMR [?? MHz, CDCl3 + (PhNH)2]: δ = 7.05 (s, 1 H), 2.67 (s, 2 H), 1.39
(s, 6 H), 1.26 (s, 6 H).
MS (EI): m/z (%) = 199 (31) [M+], 185 (31), 169 (27) 152 (42), 139
(100).
Anal. Calcd for C9H15N2O3: C, 54.26; H, 7.59; N, 14.06. Found: C, 54.12;
H, 7.55; N, 14.01.
(4,4,6,6-Tetramethyl-1,4,6,7-tetrahydro-5H-[1,2,3]triazolo[4,5-
c]pyridin-5-yl)oxidanyl (19)
NaN3 (130 mg, 2.0 mmol) was added to a solution of compound 18
(199 mg, 1.0 mmol) in DMSO (5.0 mL), and the mixture was stirred at
90 °C for 2 h. The mixture was then cooled, diluted with H2O (10 mL),
and extracted with CH2Cl2 (3 × 30 mL). The organic phases were com-
bined, dried (MgSO4), filtered, and concentrated. The crude product
was purified by column chromatography [silica gel, hexane–EtOAc
(2:1)] to give a yellow solid; yield: 92 mg (47%); mp 198–199 °C; Rf =
0.22 (hexane–EtOAc, 2:1).
IR (ATR): 3148, 3053, 2969, 2876, 1582, 1530 cm–1.
1H NMR [?? MHz, CDCl3 + (PhNH)2]: δ = 2.88 (s, 2 H), 1.65 (s, 6 H), 1.33
(s, 6 H).
MS (EI): m/z (%) = 195 (23) [M+], 165 (45), 150 (73) 122 (37), 41 (100).
Anal. Calcd for C9H15N4O: C, 55.37; H, 7.74; N, 28.70. Found: C, 55.25;
H, 7.64; N, 28.59.
[3-(Methoxycarbonyl)-4,4,6,6-tetramethyl-2,4,6,7-tetrahydro-5H-
pyrrolo[3,4-c]pyridin-5-yl]oxidanyl (20a)
DBU (729 mg, 4.8 mmol) was added dropwise to a stirred solution of
compound 18 (796 mg, 4.0 mmol) and methyl isocyanoacetate (435
mg, 4.4 mmol) in anhyd THF (10 mL) at 0 °C, and the mixture was
stirred at r.t. for 12 h. The solvent was evaporated and the residue was
partitioned between EtOAc (30 mL) and 5% aq H2SO4 (20 mL). The
phases were separated and the organic phase was dried (MgSO4), fil-
tered, and concentrated. The residue was purified by column chroma-
tography [silica gel, hexane–EtOAc (2:1)] to give a pale-orange solid;
yield: 532 mg (53%); mp 184–185 °C; Rf = 0.45 (hexane–EtOAc, 2:1).
IR (ATR): 3330, 2987, 2943, 1701, 1572, 1513 cm–1.
1H NMR [?? MHz, CDCl3+ (PhNH)2]: δ = 6.57 (s, 1 H), 3.89 (s, 3 H), 2.67
(s, 2 H), 1.79 (s, 6 H), 1.32 (s, 6 H).© Georg Thieme Verlag  Stuttgart · New York — Synthesis 2014, 46, A–G
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(100).
Anal. Calcd for C13H19N2O3: C, 62.13; H, 7.62; N, 11.15. Found: C,
62.10; H, 7.47; N, 11.05.
[3-(tert-Butoxycarbonyl)-2-(methoxycarbonyl)-4,4,6,6-tetrameth-
yl-2,4,6,7-tetrahydro-5H-pyrrolo[3,4-c]pyridin-5-yl]oxidanyl (20b)
t-BuOK (90 mg, 0.8 mmol) was added to a stirred solution of com-
pound 20a (502 mg, 2.0 mmol) and Boc2O (480 mg, 2.2 mmol) in an-
hyd THF (20 mL) at r.t., and the mixture was stirred and refluxed for
19 h. If the conversion was not complete, more Boc2O (91 mg, 0.5
mmol) and t-BuOK (22 mg, 0.2 mmol) were added, and reflux and
stirring were continued for a further 5 h. The mixture was then
cooled and concentrated, and the residue was partitioned between
brine (10 mL) and EtOAc (20 mL). The organic phase was dried
(MgSO4), filtered, concentrated, and purified by flash column chroma-
tography [silica gel, hexane–Et2O (2:1)] to give an orange solid; yield:
512 mg (73%); mp 90–91 °C; Rf = 0.27 (hexane–Et2O, 2:1).
IR (ATR): 2980, 2922, 2853, 1725, 1516 cm–1.
MS (EI): m/z (%) = 351 (38) [M+], 278 (8), 264 (13), 221 (41) 206 (60),
178 (100) 57 (70).
Anal. Calcd for C18H27N2O5: C, 61.34; H, 8.01; N, 7.95. Found: C, 61.19;
H, 7.98; N, 8.03.
11-(tert-Butoxycarbonyl)-9,10-bis(ethoxycarbonyl)-1-(methoxy-
carbonyl)-3,3,5,5-tetramethyl-4,11-diazatricyclo[6.2.1.02,7]unde-
ca-2(7),9-dien-4-yloxidanyl (21)
A solution of compound 20b (702 mg, 2.0 mmol) and EtO2CC≡CCO2Et
(680 mg, 4.0 mmol) in toluene (20 mL) was refluxed for 48 h then
cooled. The solvent was evaporated and the residue was purified by
flash column chromatography [silica gel, hexane–EtOAc (2:1)] to give
a deep-yellow oil; yield: 354 mg (34%); Rf = 0.40 (hexane–EtOAc, 2:1).
IR (ATR): 2980, 2938, 2905, 1712, 1628 cm–1.
MS (EI): m/z (%) = 521 (2) [M+], 491 (2), 391 (36), 251 (46), 178 (82),
146 (98), 57 (100).
Anal. Calcd for C26H37N2O9: C, 59.87; H, 7.15; N, 5.37. Found: C, 60.02;
H, 7.23; N, 5.25.
Acknowledgment
We are grateful to Dr. Gábor Maász for mass spectral measurements,
to Viola Csokona for elemental analyses, and to the Hungarian Nation-
al Research Fund (OTKA K81123, K104956) for financial support.
Supporting Information
Supporting information for this article is available online at
http://dx.doi.org/10.1055/s-0034-1379958. Suporting IformationSuporting Iformation
References
(1) Li, J. J. Heterocyclic Chemistry in Drug Discovery; Wiley: Hobo-
ken, 2013.
(2) Likhtenshtein, G.; Yamauchi, J.; Nakatsuji, S.; Smirnov, A. I.;
Tamura, R. Nitroxides: Applications in Chemistry Biomedicine and
Materials Science; Wiley-VCH: Weinheim, 2008.
(3) Tebben, L.; Studer, A. Angew. Chem. Int. Ed. 2011, 50, 5034.
(4) Shelke, S. A.; Sigurdsson, S. T. In Structural Information from
Spin-Labels and Intrinsic Paramagnetic Centres in the Biosci-
ences; Timmel, C.; Harmer, J. R., Eds.; Springer: Berlin, 2011,
Chap. 3, 121.
(5) Ratera, I.; Veciana, J. Chem. Soc. Rev. 2012, 41, 303.
(6) Fawzi, N. L.; Fleissner, M. R.; Anthis, N. J.; Kálai, T.; Hideg, K.;
Hubbell, W. L.; Clore, G. M. J. Biomol. NMR 2011, 51, 105.
(7) Kálai, T.; Jekő, J.; Hideg, K. Synthesis 2000, 831.
(8) Kálai, T.; Jekő, J.; Berente, Z.; Hideg, K. Synthesis 2006, 439.
(9) Kálai, T.; Balog, M.; Jekő, J.; Hideg, K. Synthesis 1998, 1476.
(10) Kulcsár, Gy.; Kálai, T.; Jekő, J.; Hideg, K. Synthesis 2003, 1361.
(11) Kálai, T.; Bagi, N.; Jekő, J.; Berente, Z.; Hideg, K. Synthesis 2010,
1702.
(12) Kálai, T.; Altman, R.; Maezawa, I.; Balog, M.; Morisseau, C.;
Petrlova, J.; Hammock, D. B.; Jin, L-W.; Trudell, J. R.; Voss, C. J.;
Hideg, K. Eur. J. Med. Chem. 2014, 77, 343.
(13) Rozantsev, E. G. Free Nitroxyl Radicals; Plenum: New York,
1970.
(14) Wong, L. T.; Schwenk, R.; Hsia, J. C. Can. J. Chem. 1974, 52, 3381.
(15) Rauckman, E. J.; Rosen, G. M.; Abou-Donia, M. B. J. Org. Chem.
1976, 41, 564.
(16) Finnegan, W. G.; Henry, R. A.; Lofquist, R. J. Am. Chem. Soc. 1958,
80, 3908.
(17) Qiao, J. X. In Name Reactions in Heterocyclic Chemistry II; Li, J. J.,
Ed.; Wiley: Hoboken, 2011, Chap. 5.5, 309.
(18) Efimova, J. A.; Artamanova, T. V.; Koldobskii, G. I. Russ. J. Org.
Chem. 2008, 44, 1345.
(19) Kokorin, A. I.; Golubeva, E. N.; Mladenova, B. Y.; Tran, V. A.;
Kálai, T.; Hideg, K.; Grammp, G. Appl. Magn. Reson. 2013, 44,
1041.
(20) Hemetsberger, K.; Knittel, D. Monatsh. Chem. 1972, 103, 194.
(21) Lehmann, F.; Holm, M.; Laufer, S. Tetrahedron Lett. 2009, 50,
1708.
(22) Hideg, K.; Hankovszky, H. O.; Lex, L.; Kulcsár, Gy. Synthesis 1980,
911.
(23) Csekő, J.; Hankovszky, H. O.; Hideg, K. Can. J. Chem. 1985, 63,
940.
(24) Murakami, Y.; Watanabe, T.; Suzuki, H.; Kotake, N.; Takahashi,
T.; Toyonari, K.; Ohno, M.; Takase, K.; Suzuki, T.; Kondo, K. Chem.
Pharm. Bull. 1997, 45, 1739.
(25) Kálai, T.; Balog, M.; Szabó, A.; Gulyás, G.; Jekő, J.; Sümegi, B.;
Hideg, K. J. Med. Chem. 2009, 52, 1619.
(26) Hideg, K.; Sár, P. C.; Hankovszky, H. O.; Tamás, T.; Jerkovich, Gy.
Synthesis 1993, 390.
(27) Kálai, T.; Rozsnyai, B.; Jerkovich, Gy.; Hideg, K. Synthesis 1994,
1079.
(28) (a) Barton, D. H. R.; Zard, S. Z. J. Chem. Soc., Chem. Commun.
1985, 1098. (b) Gribble, G. W. In Name Reactions in Heterocyclic
Chemistry; Li, J. J.; Corey, E. J., Eds.; Wiley: Hoboken, 2005, Chap.
2.1, 69.
(29) Miskina, L. A.; Podvigina, L. F. Izv. Akad. Nauk, Ser. Khim. 1982,
1338; Chem. Abstr. 1982, 97, 109838.
(30) Keene, C.; Kürti, L. Synthesis 2013, 45, 1719.
(31) Ono, N.; Kawamura, H.; Bougauchi, M.; Murayama, K. Tetrahe-
dron 1990, 46, 7483.
(32) Kaiser, H. P.; Muchowski, J. M. J. Org. Chem. 1984, 49, 4203.
(33) Kálai, T.; Bognár, B.; Zsolnai, D.; Berente, Z.; Hideg, K. Synthesis
2012, 44, 3655.© Georg Thieme Verlag  Stuttgart · New York — Synthesis 2014, 46, A–G
